| Literature DB >> 16293761 |
May Tassabehji1, Peter Hammond, Annette Karmiloff-Smith, Pamela Thompson, Snorri S Thorgeirsson, Marian E Durkin, Nicholas C Popescu, Timothy Hutton, Kay Metcalfe, Agnes Rucka, Helen Stewart, Andrew P Read, Mark Maconochie, Dian Donnai.
Abstract
Craniofacial abnormalities account for about one-third of all human congenital defects, but our understanding of the genetic mechanisms governing craniofacial development is incomplete. We show that GTF2IRD1 is a genetic determinant of mammalian craniofacial and cognitive development, and we implicate another member of the TFII-I transcription factor family, GTF2I, in both aspects. Gtf2ird1-null mice exhibit phenotypic abnormalities reminiscent of the human microdeletion disorder Williams-Beuren syndrome (WBS); craniofacial imaging reveals abnormalities in both skull and jaws that may arise through misregulation of goosecoid, a downstream target of Gtf2ird1. In humans, a rare WBS individual with an atypical deletion, including GTF2IRD1, shows facial dysmorphism and cognitive deficits that differ from those of classic WBS cases. We propose a mechanism of cumulative dosage effects of duplicated and diverged genes applicable to other human chromosomal disorders.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16293761 DOI: 10.1126/science.1116142
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728